ImCheck Therapeutics Appoints Dr. Loui Madakamutil as CSO

NEXT STORY
Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress
PREV STORY
While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inolimomab, the company confirms the renew of its cohort ATU in France and compassionate use programs submissions in several other countries
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CytomX Therapeutics Presents Clinical Data from Probody™ Platform and CX-072 at 2018 ESMO Annual Meeting

- Additional Data Supports PD-L1 Targeting Probody CX-072 as Well Tolerated with Antitumor Activity ...

author_avatar
NASDAQ Market News

iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Longeveron Announces Successful Completion of Phase I/II Clinical Study of Lomecel-B Infusion in Aging Frailty Subjects to Improve Immune Response Following Influenza Vaccination

author_avatar
NASDAQ Market News